BioInfra (A199730) Stock Overview
Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
A199730 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
BioInfra Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩4,625.00 |
| 52 Week High | ₩7,620.00 |
| 52 Week Low | ₩4,535.00 |
| Beta | 0.71 |
| 1 Month Change | -6.85% |
| 3 Month Change | -14.19% |
| 1 Year Change | -31.89% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -84.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| A199730 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | 1.2% | -11.6% | -0.6% |
| 1Y | -31.9% | 18.6% | 55.4% |
Return vs Industry: A199730 underperformed the KR Life Sciences industry which returned 18.6% over the past year.
Return vs Market: A199730 underperformed the KR Market which returned 55.4% over the past year.
Price Volatility
| A199730 volatility | |
|---|---|
| A199730 Average Weekly Movement | 3.6% |
| Life Sciences Industry Average Movement | 7.4% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in KR Market | 11.0% |
| 10% least volatile stocks in KR Market | 2.6% |
Stable Share Price: A199730 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A199730's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | n/a | n/a | www.bioinfrakorea.co.kr |
Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. Its primary product is a bioequivalence test for generic drugs, a phase 1 test for incrementally modified drugs; and a phase 1 sample analysis for other new substances. The company was founded in 2007 and is based in Yongin-si, South Korea.
BioInfra Co., Ltd. Fundamentals Summary
| A199730 fundamental statistics | |
|---|---|
| Market cap | ₩22.50b |
| Earnings (TTM) | -₩5.63b |
| Revenue (TTM) | ₩21.92b |
Is A199730 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A199730 income statement (TTM) | |
|---|---|
| Revenue | ₩21.92b |
| Cost of Revenue | ₩17.05b |
| Gross Profit | ₩4.87b |
| Other Expenses | ₩10.50b |
| Earnings | -₩5.63b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.16k |
| Gross Margin | 22.23% |
| Net Profit Margin | -25.67% |
| Debt/Equity Ratio | 53.3% |
How did A199730 perform over the long term?
See historical performance and comparisonDividends
Does A199730 pay a reliable dividends?
See A199730 dividend history and benchmarks| BioInfra dividend dates | |
|---|---|
| Ex Dividend Date | Dec 29 2025 |
| Dividend Pay Date | Apr 24 2026 |
| Days until Ex dividend | 30 days |
| Days until Dividend pay date | 146 days |
Does A199730 pay a reliable dividends?
See A199730 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/28 23:23 |
| End of Day Share Price | 2025/11/28 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BioInfra Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.